Total Payments
$8,386
2024 Payments
$461.17
Companies
48
Transactions
746
Medicare Patients
2,433
Medicare Billing
$329,639
Payment Breakdown by Category
Food & Beverage$7,765 (92.6%)
Consulting$550.00 (6.6%)
Education$71.10 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,765 | 742 | 92.6% |
| Consulting Fee | $550.00 | 3 | 6.6% |
| Education | $71.10 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $2,467 | 207 | $0 (2023) |
| UCB, Inc. | $971.24 | 133 | $0 (2022) |
| ABBVIE INC. | $933.74 | 106 | $0 (2024) |
| Allergan, Inc. | $482.22 | 47 | $0 (2021) |
| Amgen Inc. | $298.96 | 20 | $0 (2023) |
| LivaNova USA, Inc. | $270.79 | 15 | $0 (2022) |
| Cyberonics, Inc. | $264.86 | 2 | $0 (2017) |
| Eisai Inc. | $254.82 | 14 | $0 (2021) |
| Lilly USA, LLC | $245.43 | 16 | $0 (2023) |
| ARGENX US, INC. | $240.04 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $461.17 | 35 | ABBVIE INC. ($264.07) |
| 2023 | $603.06 | 44 | AbbVie Inc. ($160.13) |
| 2022 | $439.69 | 38 | ABBVIE INC. ($133.30) |
| 2021 | $1,552 | 134 | Biogen, Inc. ($523.40) |
| 2020 | $1,139 | 98 | Biogen, Inc. ($358.73) |
| 2019 | $1,435 | 146 | Biogen, Inc. ($425.95) |
| 2018 | $1,084 | 118 | Biogen, Inc. ($374.32) |
| 2017 | $1,672 | 133 | Biogen, Inc. ($600.56) |
All Payment Transactions
746 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Neurology | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Neurology | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Neurology | ||||||
| 09/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Neurology | ||||||
| 09/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Neurology | ||||||
| 08/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Neurology | ||||||
| 07/11/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $32.21 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: Neurology | ||||||
| 06/06/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: Neurology | ||||||
| 05/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Neurology | ||||||
| 05/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Obesity | ||||||
| 05/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 667 | 916 | $241,606 | $89,084 |
| 2022 | 7 | 622 | 847 | $217,184 | $82,561 |
| 2021 | 8 | 571 | 831 | $204,975 | $83,921 |
| 2020 | 8 | 573 | 810 | $246,572 | $74,073 |
Total Patients
2,433
Total Services
3,404
Medicare Billing
$329,639
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 222 | 353 | $52,597 | $21,382 | 40.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 160 | 160 | $52,320 | $18,356 | 35.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 50 | 50 | $35,850 | $14,218 | 39.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 158 | $34,760 | $13,868 | 39.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 60 | 130 | $32,500 | $9,652 | 29.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 39 | 39 | $17,823 | $6,044 | 33.9% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 26 | 26 | $15,756 | $5,564 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 230 | 372 | $55,428 | $23,369 | 42.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 153 | 153 | $49,924 | $17,804 | 35.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 42 | 42 | $30,114 | $12,439 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 107 | $23,540 | $9,237 | 39.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 54 | 116 | $29,000 | $9,106 | 31.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 36 | 36 | $16,452 | $5,817 | 35.4% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 21 | 21 | $12,726 | $4,788 | 37.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 215 | 389 | $57,961 | $25,409 | 43.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 137 | 137 | $44,799 | $16,741 | 37.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 91 | 127 | $27,540 | $11,454 | 41.6% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2021 | 25 | 25 | $17,925 | $7,288 | 40.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 40 | 90 | $17,370 | $7,241 | 41.7% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 19 | 19 | $16,143 | $6,636 | 41.1% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2021 | 21 | 21 | $12,726 | $5,043 | 39.6% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 23 | 23 | $10,511 | $4,108 | 39.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 224 | 398 | $69,224 | $20,879 | 30.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 141 | 141 | $54,372 | $17,534 | 32.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 94 | 120 | $31,100 | $9,671 | 31.1% |
About Dr. Brandon Woods, MD
Dr. Brandon Woods, MD is a Neurology healthcare provider based in Sun City, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2011. The National Provider Identifier (NPI) number assigned to this provider is 1164713749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brandon Woods, MD has received a total of $8,386 in payments from pharmaceutical and medical device companies, with $461.17 received in 2024. These payments were reported across 746 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($7,765).
As a Medicare-enrolled provider, Woods has provided services to 2,433 Medicare beneficiaries, totaling 3,404 services with total Medicare billing of $329,639. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Sun City, AZ
- Active Since 04/29/2011
- Last Updated 04/14/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1164713749
Products in Payments
- TECFIDERA (Drug) $760.85
- TYSABRI (Biological) $748.08
- Briviact (Drug) $564.29
- UBRELVY (Drug) $552.91
- VUMERITY (Drug) $462.58
- VNS Therapy (Device) $438.04
- BOTOX (Biological) $418.94
- AVONEX (Biological) $414.29
- Neupro (Drug) $307.59
- QULIPTA (Drug) $264.66
- Fycompa (Drug) $243.88
- MIGRANAL (Drug) $228.11
- EMGALITY (Drug) $214.08
- VYVGART HYTRULO (Drug) $195.43
- NURTEC ODT (Drug) $171.34
- Zembrace (Drug) $140.12
- Aimovig (Biological) $137.84
- DUOPA (Drug) $115.68
- Ozempic (Drug) $110.80
- Vimpat (Drug) $99.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Sun City
Dr. David Shprecher, D.o, D.O
Neurology — Payments: $404,947
Neurology $404,947
Holly Laub, Do, DO
Neurology — Payments: $36,188
Neurology $36,188
Dr. Maninder Kahlon, M.d, M.D
Neurology — Payments: $20,855
Neurology $20,855
Sara Dhanani, M.d, M.D
Neurology — Payments: $17,103
Neurology $17,103
Seth Larson, Md, MD
Neurology — Payments: $722.23
Neurology $722.23
Dr. Kenneth Harris, Md, MD
Neurology — Payments: $48.99
Neurology $48.99